Brentuximab Vedotin in Combination with Bendamustine for Patients with Hodgkin Lymphoma who are Relapsed or Refractory after Frontline Therapy

Ann LaCasce; R. Gregory Bociek; Jeffrey Matous; Ahmed Sawas; Paolo Caimi; Stephen M. Ansell; Miguel Islas-Ohlmayer; Eric Cheung; Edward Agura; Caroline Behler; Howland Crosswell; Julie M. Vose; Neil Josephson; Ranjana Advani

doi:10.1182/BLOOD.V124.21.293.293

Brentuximab Vedotin in Combination with Bendamustine for Patients with Hodgkin Lymphoma who are Relapsed or Refractory after Frontline Therapy

Ann LaCasce
, R. Gregory Bociek
, Jeffrey Matous
, Ahmed Sawas
, Paolo Caimi
, Stephen M. Ansell
, Miguel Islas-Ohlmayer
, Eric Cheung
, Edward Agura
, Caroline Behler
, Howland Crosswell
, Julie M. Vose
, Neil Josephson
, Ranjana Advani

Harvard University
University of Nebraska Medical Center
Colorado Blood Cancer Institute, Denver, CO
Columbia University Medical Center
Case Western Reserve University
Mayo Clinic
Jewish Hospital
The Oncology Institute of Hope & Innovation, Whittier, CA
Charles A. Sammons Cancer Center, Dallas, TX
Pacific Hematology Oncology Associates, San Francisco, CA
St. Francis Hospital, Greenville, SC
Seattle Genetics
Stanford University

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	124
Issue number	21
DOIs	https://doi.org/10.1182/BLOOD.V124.21.293.293
State	Published - Dec 6 2014
Externally published	Yes

Disciplines

Medicine and Health Sciences
Oncology
Surgery
Internal Medicine

Access to Document

10.1182/BLOOD.V124.21.293.293License: Unspecified

Cite this

LaCasce, A., Bociek, R. G., Matous, J., Sawas, A., Caimi, P., Ansell, S. M., Islas-Ohlmayer, M., Cheung, E., Agura, E., Behler, C., Crosswell, H., Vose, J. M., Josephson, N., & Advani, R. (2014). Brentuximab Vedotin in Combination with Bendamustine for Patients with Hodgkin Lymphoma who are Relapsed or Refractory after Frontline Therapy. Blood, 124(21). https://doi.org/10.1182/BLOOD.V124.21.293.293

LaCasce, A, Bociek, RG, Matous, J, Sawas, A, Caimi, P, Ansell, SM, Islas-Ohlmayer, M, Cheung, E, Agura, E, Behler, C, Crosswell, H, Vose, JM, Josephson, N & Advani, R 2014, 'Brentuximab Vedotin in Combination with Bendamustine for Patients with Hodgkin Lymphoma who are Relapsed or Refractory after Frontline Therapy', Blood, vol. 124, no. 21. https://doi.org/10.1182/BLOOD.V124.21.293.293

@article{60ac27e69b7e4d8eba8f7fa9641c0208,

title = "Brentuximab Vedotin in Combination with Bendamustine for Patients with Hodgkin Lymphoma who are Relapsed or Refractory after Frontline Therapy",

author = "Ann LaCasce and Bociek, \{R. Gregory\} and Jeffrey Matous and Ahmed Sawas and Paolo Caimi and Ansell, \{Stephen M.\} and Miguel Islas-Ohlmayer and Eric Cheung and Edward Agura and Caroline Behler and Howland Crosswell and Vose, \{Julie M.\} and Neil Josephson and Ranjana Advani",

note = "624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Targeting PD1 and CD30 in Hodgkin Lymphoma and NHL | Ann LaCasce, R. Gregory Bociek, Jeffrey Matous, Ahmed Sawas, Paolo Caimi, Stephen M. Ansell, Miguel Islas-Ohlmayer, Eric Cheung, Edward Agura, Caroline Behler, Howland Crosswell, Julie M.",

year = "2014",

month = dec,

day = "6",

doi = "10.1182/BLOOD.V124.21.293.293",

language = "American English",

volume = "124",

journal = "Blood",

publisher = "American Society of Hematology",

number = "21",

}

TY - JOUR

T1 - Brentuximab Vedotin in Combination with Bendamustine for Patients with Hodgkin Lymphoma who are Relapsed or Refractory after Frontline Therapy

AU - LaCasce, Ann

AU - Bociek, R. Gregory

AU - Matous, Jeffrey

AU - Sawas, Ahmed

AU - Caimi, Paolo

AU - Ansell, Stephen M.

AU - Islas-Ohlmayer, Miguel

AU - Cheung, Eric

AU - Agura, Edward

AU - Behler, Caroline

AU - Crosswell, Howland

AU - Vose, Julie M.

AU - Josephson, Neil

AU - Advani, Ranjana

N1 - 624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Targeting PD1 and CD30 in Hodgkin Lymphoma and NHL | Ann LaCasce, R. Gregory Bociek, Jeffrey Matous, Ahmed Sawas, Paolo Caimi, Stephen M. Ansell, Miguel Islas-Ohlmayer, Eric Cheung, Edward Agura, Caroline Behler, Howland Crosswell, Julie M.

PY - 2014/12/6

Y1 - 2014/12/6

UR - https://ashpublications.org/blood/article/124/21/293/96559/Brentuximab-Vedotin-in-Combination-with

U2 - 10.1182/BLOOD.V124.21.293.293

DO - 10.1182/BLOOD.V124.21.293.293

M3 - Article

VL - 124

JO - Blood

JF - Blood

IS - 21

ER -

Brentuximab Vedotin in Combination with Bendamustine for Patients with Hodgkin Lymphoma who are Relapsed or Refractory after Frontline Therapy

Disciplines

Access to Document

Other files and links

Cite this